BN
CRL icon

Bill Nygren’s Charles River Laboratories CRL Stock Holding History

Bill Nygren’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508M Buy
2,241,144
+87,848
+4% +$15.6M 0.67% 55
2026
Q1 		$371M Buy
2,153,296
+475,690
+28% +$88.2M 0.5% 64
2025
Q4 		$335M Buy
1,677,606
+204,522
+14% +$37.1M 0.42% 61
2025
Q3 		$230M Buy
1,473,084
+310,149
+27% +$49.3M 0.37% 63
2025
Q2 		$176M Buy
+1,162,935
New +$155M 0.29% 68

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bill Nygren's CRL Position: Q2 2026 in Review

Bill Nygren increased its Charles River Laboratories (CRL) stake by 4.1% in Q2 2026, buying an estimated $15.6M and bringing the position to 2,241,144 shares worth $508M. The position accounts for 0.67% of the portfolio, ranked #55.

Bill Nygren first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Bill Nygren held 2,241,144 shares of Charles River Laboratories worth $508M as of Q2 2026.
  • Bill Nygren bought 87,848 Charles River Laboratories shares in Q2 2026, an estimated $15.6M.
  • Charles River Laboratories made up 0.67% of Bill Nygren's portfolio in Q2 2026, its #55 holding.
  • Bill Nygren first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Harris Associates's 13F filing for Q2 2026, filed 14 Aug 2026.